Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.

Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.

Item

http://www.wikidata.org/entity/Q30649180

Q30649180

about

Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients The basics of diffusion and perfusion imaging in brain tumors Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor Pros and cons of current brain tumor imaging Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imagin Investigation of Apparent Diffusion Coefficient from Ultra-high b-Values in Parkinson's Disease.Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.Detecting tumor progression in glioma: Current standards and new techniques.Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.Extracellular diffusion quantified by magnetic resonance imaging during rat C6 glioma cell progression Impact of imaging measurements on response assessment in glioblastoma clinical trials Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.Characterization and Correction of Geometric Distortions in 814 Diffusion Weighted Images Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging.Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.MR-guided radiation therapy: transformative technology and its role in the central nervous system.Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.Current Clinical Brain Tumor Imaging An Update on the Approach to the Imaging of Brain Tumors.Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence Stratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation.Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.Standard-b-value vs low-b-value DWI for differentiation of benign and malignant vertebral fractures: a meta-analysis Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches.Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomi Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics.Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.Comment on "The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline" [J Neurooncol 2014; 118:435-460].Feasibility and applicability of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in routine assessments of children with high-grade gliomas.Differentiation of edema and glioma infiltration: proposal of a DTI-based probability map.Prognostic value of post-treatment metabolic tumor volume from 11C-methionine PET/CT in recurrent malignant glioma.Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion.Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.

P2860

Q27344690-7F276C38-686B-42E0-AACE-4A2F1EC38065 Q28066044-1E1C09D7-A0EE-480A-A8B7-AC770BB3424D Q28606582-911DE7DE-9C8D-46EA-88AE-69D0F7C47579 Q30838169-E62680AD-0BFB-4446-A89E-2439357FBAD7 Q30860126-B52E6B87-255F-4E4B-9FFA-5BFDF7CA3338 Q30871297-E2FE8A25-F8C6-4D02-A1C1-FD996532B393 Q30906473-ABC9AFE9-0EE4-4E12-B657-D0C5E81A1FF0 Q31038332-67F1D941-7996-4151-B4C4-F5D59C85556F Q31130812-863075AF-6FB0-43F4-81AE-89F886EFF96D Q31132701-6FAE6A9D-B6C0-413C-86EF-17D6AC89C602 Q33698886-EAEA3AFA-1D36-40CD-9B33-3F2613F7C7A2 Q33868274-2B85E95E-771D-48E8-9FFF-8B761C626758 Q34331328-06805800-4998-4C23-A950-DAA116639F90 Q35771783-EB2EE6DE-B462-4049-A9D6-B689233C217B Q35973830-35D4E65D-7C1D-4CE1-B5EF-53C2828AA5D7 Q36279879-6246C2A7-F190-4208-8071-43DD21D9A611 Q36324977-87A1A419-83D3-4E88-9CA3-FA6A2D1714D0 Q36336361-E59CBEBF-3C59-43F1-85A6-279D7FBB487B Q36361484-29A5E08D-F960-44E5-8C15-EB900F2E51D0 Q36367172-6EF3C88D-80C0-43E1-AF22-E0B158FC06B6 Q36374577-E93DB4ED-85CE-4089-B158-2131125383D7 Q36515232-5B98EC8F-E290-4287-A4F4-7D248816F9CB Q37321862-D0F2BC8E-5FE8-4D35-832A-EDA264EB9556 Q38266418-B42E139C-6378-447F-83AC-AC4F28B96C58 Q38975001-BBA9371B-3464-4E5F-B4DF-E3E54BF64E93 Q39030177-34697D5A-D88D-4EF0-A8B8-498FF71E23F2 Q39312420-1C2DF2BB-5FD4-4436-8C71-A161727510A6 Q40892621-01DDA618-A508-49A4-B166-D53D8D2D5C0A Q45945185-64D18B07-51B7-4719-9F59-F02531965392 Q47406548-A53B79FC-FFE4-4901-A071-96D073539579 Q47993560-E0C82F89-D3EC-4ECC-AC6B-CEA3605EFDA2 Q47997045-75C16E57-49FA-4E2B-B260-48BC2F928EB1 Q48155295-D97E89F3-C002-4881-A857-C2FD06ECF41B Q48467664-1D22C31A-A5CE-4E8E-AC8F-F2EF19561C63 Q48519926-82392BDB-D6CC-4618-B4D2-F42C7F07853C Q48627951-1A822451-B440-4180-82D6-C5E04CBBBC14 Q48686036-6E191029-D301-479B-859D-F4E65CD88832 Q48904998-7A00CD83-D368-4361-ABE2-257AF6FD1282 Q48906044-85E057B6-C1E7-4EBB-9C14-48B1ABA565AA Q48930260-45C642AF-66C7-4449-A653-BB4B94A3BFD4

P2860

Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.

Item

http://www.wikidata.org/entity/Q30649180

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu